文献速递消化道肿瘤与早癌消化内镜

结肠镜与粪便免疫化学检测:孰优孰劣

Colonoscopy vs the Fecal Immunochemical Test: Which is Best?
PubMed 文献 · Gastroenterology · 2024-02-09

本文综述结直肠癌筛查中结肠镜与粪便免疫化学检测(FIT)两种最常用方法。美国指南列出多种选择,大规模比较效果试验尚未有结果。本文分别陈述FIT和结肠镜作为首选筛查工具的「最佳情形」,并从健康经济学角度分析两者相对优势。

要点

  • 结肠镜与FIT均为美国指南推荐的结直肠癌筛查选项
  • 比较两者对结直肠癌结局的大规模试验正在进行,结果未出
  • 从健康经济学角度可提供两种筛查方法相对优势的更多背景

核心结论

  • 结肠镜与FIT作为结直肠癌筛查首选工具各有其「最佳情形」,需从健康经济学角度理解相对优势。

主要发现

  • 美国指南列出包括结肠镜和FIT在内的多种筛查选项。
  • 比较结肠镜与FIT对结直肠癌结局的大规模比较效果试验正在进行,结果尚未可用。

局限性

  • 比较结肠镜与FIT对结直肠癌结局的大规模试验结果尚未获得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although there is no debate around the effectiveness of colorectal cancer screening in reducing disease burden, there remains a question regarding the most effective and cost-effective screening modality. Current United States guidelines present a panel of options that include the 2 most commonly used modalities, colonoscopy and stool testing with the fecal immunochemical test (FIT). Large-scale comparative effectiveness trials comparing colonoscopy and FIT for colorectal cancer outcomes are underway, but results are not yet available. This review will separately state the "best case" for FIT and colonoscopy as the screening tool of first choice. In addition, the review will examine these modalities from a health economics perspective to provide the reader further context about the relative advantages of these commonly used tests.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Robertson DJ, Rex DK, Ciani O, et al. Colonoscopy vs the Fecal Immunochemical Test: Which is Best? Gastroenterology. 2024. PMID: 38342196. doi:10.1053/j.gastro.2023.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。